Short‐term cyclosporin A treatment improves pregnancy outcomes in patients with unexplained pregnancy loss: A prospective, open‐label, observational study

Abstract Background Various treatments to improve live birth rate in women suffering unexplained recurrent pregnancy loss (URPL) have proven ineffective. Cyclosporin A (CsA), an immunosuppressant widely used in organ transplantation, can induce maternal–foetal immune tolerance and improve trophoblas...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Mei‐Rong Du, Ming‐Qing Li, Wen‐Jie Zhou, Da‐Jin Li
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2022-12-01
Reeks:	Clinical and Translational Discovery
Onderwerpen:	cyclosporin A efficacy live birth rate risk factors safety unexplained pregnancy losses
Online toegang:	https://doi.org/10.1002/ctd2.135
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!